Starting plasma exchange — a procedure to replace a portion of a patient’s blood with that of a healthy donor — within one day of…
News
IMMUNE THROMBOCYTOPENIA
NewsDigital tool aims to teach mothers how to protect ITP children from infection
A three-week educational program delivered through WhatsApp may help mothers of children with immune thrombocytopenia (ITP) prevent Helicobacter pylori infection, a bacterial infection that…
IMMUNE THROMBOCYTOPENIA
NewsScientists spot potential new markers for treating chronic ITP
Researchers in Turkey have uncovered changes in immune cells and surface proteins on platelets, which are tiny, colorless cell fragments in the blood that help…
VON WILLEBRAND DISEASE
NewsRare von Willebrand case resolves after rectal cancer treatment: Report
The case of a woman whose von Willebrand syndrome (VWS) resolved spontaneously after being treated for rectal cancer, was reported in a recent study.
IMMUNE THROMBOCYTOPENIA
NewsPlatelets shift into high gear in active ITP, study shows
Platelets in active immune thrombocytopenia (ITP) have unique changes in genetic activity that make them more activated than platelets from healthy people or from…
IMMUNE THROMBOCYTOPENIA
NewsAggressive blood cancer masquerades as primary ITP: Case report
An elderly man initially thought to have primary immune thrombocytopenia (ITP), which occurs without an identifiable underlying cause, was later found to have a…
VON WILLEBRAND DISEASE
NewsAcquired von Willebrand syndrome has two unique profiles, study finds
Acquired von Willebrand syndrome (AVWS) mainly presents as two distinct clinical and laboratory profiles, depending on the underlying blood condition, according to a new study.
New classes of second-line drugs targeting the immune pathways involved in the autoimmune attacks that cause immune thrombocytopenia (ITP) significantly boost platelet counts in…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsiTTP remission may still carry higher stroke risk, study finds
People in remission from immune-mediated thrombotic thrombocytopenic purpura (iTTP) may have a higher risk of certain major cardiovascular events, particularly stroke, according to a…
IMMUNE THROMBOCYTOPENIA
NewsWayrilz wins approval in Japan for treating hard-to-manage ITP
Regulatory authorities in Japan have approved Sanofi’s oral therapy Wayrilz (rilzabrutinib) for treating people with immune thrombocytopenia (ITP) who haven’t responded to,…
Recent Posts
- Early blood treatment cuts by half in-hospital death risk in iTTP
- When chronic illness makes being a good friend harder
- Digital tool aims to teach mothers how to protect ITP children from infection
- My sons love to roughhouse, and I’ve got the bruises to prove it
- Scientists spot potential new markers for treating chronic ITP
